Works matching IS 22965270 AND DT 2019 AND VI 42
Results: 171
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 1, doi. 10.1159/000505166
- Publication type:
- Article
OnkoImmun 9.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. I, doi. 10.1159/000504866
- Publication type:
- Article
Contents, Vol. 42, 2019.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. I, doi. 10.1159/000504904
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 703, doi. 10.1159/000504832
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 700, doi. 10.1159/000504831
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 699, doi. 10.1159/000504830
- Publication type:
- Article
Dosisdichte Chemotherapie mit G-CSF-Unterstützung bestätigt.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 687, doi. 10.1159/000504828
- Publication type:
- Article
Hämophagozytische Lymphohistiozytose: Lebensbedrohliche Erkrankung gezielt behandeln.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 688, doi. 10.1159/000504827
- Publication type:
- Article
CAR-T-Zell-Therapie bei aggressiven Lymphomen.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 694, doi. 10.1159/000504826
- Publication type:
- Article
NSCLC: Real-Life-Studie VARGADO adressiert Fragen zur Therapiesequenz.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 696, doi. 10.1159/000504825
- Publication type:
- Article
Elotuzumab-Triplette - Verdopplung des progressionsfreien Überlebens.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 692, doi. 10.1159/000504821
- Publication type:
- Article
Überlebensverlängerung durch den CDK4 & 6 Inhibitor Abemaciclib.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 690, doi. 10.1159/000504791
- Publication type:
- Article
Acknowledgement to Reviewers.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 684, doi. 10.1159/000504499
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 710, doi. 10.1159/000504460
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 1, doi. 10.1159/000504814
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 618, doi. 10.1159/000504206
- Publication type:
- Article
Cabozantinib, der neue Standard-TKI?
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 616, doi. 10.1159/000504205
- Publication type:
- Article
Chemoradiotherapy with Concurrent Regional Arterial Chemotherapy for Locally Bulky Unresectable Rectal Cancer: A Case Series.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 678, doi. 10.1159/000502802
- By:
- Publication type:
- Article
Platelet-Lymphocyte Ratio as a Predictor of Prognosis in Head and Neck Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 665, doi. 10.1159/000502750
- By:
- Publication type:
- Article
Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 629, doi. 10.1159/000502749
- By:
- Publication type:
- Article
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 660, doi. 10.1159/000502801
- By:
- Publication type:
- Article
Oncologic Outcome of Patients with (Low-Risk) Endometrial Carcinoma Undergoing Laparotomy versus Minimally Invasive Hysterectomy: A Retrospective Analysis.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 636, doi. 10.1159/000502757
- By:
- Publication type:
- Article
Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 12, p. 650, doi. 10.1159/000502751
- By:
- Publication type:
- Article
Herausforderungen bei MRD+ oder rezidivierter PH+ ALL.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 614, doi. 10.1159/000504204
- Publication type:
- Article
Carfilzomib: Zweimal wöchentliche Gabe.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 612, doi. 10.1159/000504203
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 620, doi. 10.1159/000503842
- Publication type:
- Article
Current State of Sarcoma Care in Germany: Results of an Online Survey of Physicians.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 589, doi. 10.1159/000502758
- By:
- Publication type:
- Article
Impressive Response to Capecitabine in a Patient with Obstructive Jaundice due to Metastatic Triple-Negative Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 607, doi. 10.1159/000502756
- By:
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 542, doi. 10.1159/000503618
- Publication type:
- Article
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 599, doi. 10.1159/000502755
- By:
- Publication type:
- Article
The Glypican-4 Gene Polymorphism rs1048369 and Susceptibility to Epstein-Barr Virus-Positive and -Negative Nasopharyngeal Carcinoma in Northern China.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 572, doi. 10.1159/000502753
- By:
- Publication type:
- Article
Impact of Obesity on Clinical Outcomes in Patients with Early-Stage Cervical Cancer after Radical Hysterectomy with Pelvic Node Dissection.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 553, doi. 10.1159/000502752
- By:
- Publication type:
- Article
MicroRNA-449a Is Downregulated in Cervical Cancer and Inhibits Proliferation, Migration, and Invasion.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 564, doi. 10.1159/000502122
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 1, doi. 10.1159/000503945
- Publication type:
- Article
Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 11, p. 580, doi. 10.1159/000502754
- By:
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 541, doi. 10.1159/000503617
- Publication type:
- Article
Atezolizumab als erstes Krebsimmuntherapeutikum beim SCLC zugelassen.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 539, doi. 10.1159/000503616
- Publication type:
- Article
ASCO 2019: Metastasiertes Mammakarzinom – erstmals OS-Vorteil mit CDK4/6-Inhibitor plus endokrine Therapie.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 537, doi. 10.1159/000503241
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 543, doi. 10.1159/000502722
- Publication type:
- Article
Post-Myelofibrosis Acute Myeloid Leukemia Effectively Treated with a Combination of Ruxolitinib and 5-Azacytidine.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 532, doi. 10.1159/000502121
- By:
- Publication type:
- Article
Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 516, doi. 10.1159/000502120
- By:
- Publication type:
- Article
Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Non-Small Cell Lung Cancer: A Meta-Analysis.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 523, doi. 10.1159/000501726
- By:
- Publication type:
- Article
The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 506, doi. 10.1159/000501595
- By:
- Publication type:
- Article
Association between Preoperative Pelvic Irradiation and Toxicity of Subsequent Chemotherapy in Rectal Cancer.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 10, p. 497, doi. 10.1159/000501341
- By:
- Publication type:
- Article
Front & Back Matter.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. N.PAG, doi. 10.1159/000502966
- Publication type:
- Article
Meetings and Conferences.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. 493, doi. 10.1159/000502729
- Publication type:
- Article
PharmaNews.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. 484, doi. 10.1159/000502728
- Publication type:
- Article
Trastuzumab-Biosimilar für das HER2-positive Mamma- und Magenkarzinom.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. 482, doi. 10.1159/000502727
- Publication type:
- Article
Anforderungen an ein modernes CML-Management.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. 480, doi. 10.1159/000502726
- Publication type:
- Article
Society Bulletins.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 9, p. 489, doi. 10.1159/000501979
- Publication type:
- Article